LabTurbo Biotech

LabTurbo Biotech Payables Turnover

The Payables Turnover Ratio of LabTurbo Biotech (7725.TWO) as of Nov 21, 2026 is 7.52. In the previous year, Payables Turnover Ratio was 27.64 — a change of -72.78% (lower).

Payables Turnover

7.52

YoY

-72.78%

Last updated:

Payables Turnover Ratio of LabTurbo Biotech is 2024 7.52 . Payables Turnover Ratio of LabTurbo Biotech was 2023 27.64 . It decreases by -72.78% lower compared to the previous year.

The LabTurbo Biotech Payables Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Payables Turnover
Date
Payables Turnover
Jan 1, 2021
3.13 TWD
Jan 1, 2022
10.81 TWD
Jan 1, 2023
27.64 TWD
Jan 1, 2024
7.52 TWD
The LabTurbo Biotech Payables Turnover history
YEARPayables TurnoverYoY
7.52-72.78%
27.64+155.60%
10.81+245.71%
3.13—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LabTurbo Biotech Stock analysis

What does LabTurbo Biotech do? LabTurbo Biotech Corp generates revenue through its fully automated precision medical genetic testing systems and reagent kits, sold domestically and internationally. The company offers the LabTurbo AIO device for nucleic acid extraction, alongside nucleic acid extraction reagents and multi-specimen genetic testing reagents. Its testing services and sports science centers also contribute to revenue streams. Domestic and international customers purchase these products and services for medical and sports science applications. The firm's primary products are LabTurbo AIO, nucleic acid extraction reagents, and multi-specimen genetic testing reagents. These are sold to healthcare providers, laboratories, and sports science centers. The company's international sales target global healthcare markets, while domestic sales focus on Taiwan's health sector. Testing services are provided to clients seeking genetic analysis without purchasing equipment. LabTurbo Biotech Corp's revenue model combines hardware sales, consumable reagents, and service offerings. The LabTurbo AIO device is a key hardware product, while reagents represent recurring revenue through repeat purchases. Testing services cater to clients needing immediate genetic analysis, and sports science centers operate as a separate revenue stream within the company's diversified business. LabTurbo Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LabTurbo Biotech stock

Payables Turnover Ratio of LabTurbo Biotech is 7.52 in 2024.

Payables Turnover Ratio of LabTurbo Biotech changed from 27.64 to 7.52, representing a -72.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Payables Turnover Ratio LabTurbo Biotech since 2006 – with annual values, charts, and detailed analysis.

Payables turnover measures how quickly a company pays its suppliers. Lower turnover may indicate better payment terms or cash flow management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Payables Turnover Ratio's LabTurbo Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Payables Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Payables Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — LabTurbo Biotech

All Key Metrics — LabTurbo Biotech